NEW YORK, Feb. 9, 2021 /PRNewswire/ -- Longview
Acquisition Corp. (NYSE: LGVW.U, LGVW, LGVW WS) , a special purpose
acquisition company sponsored by an affiliate of Glenview Capital
Management, LLC, reminds it shareholders to vote at the upcoming
Special Meeting on Friday, February 12,
2021, to approve the proposed business combination with
Butterfly Network, Inc.
The affirmative vote of a majority of the outstanding shares is
needed to approve the transaction and every shareholder's vote is
important, regardless of the number of shares held. Longview
requests that each shareholder of record as of the close of
business on January 15, 2021
complete, sign, date and return a proxy card, if it has not already
done so, to ensure that the shareholder's shares will be
represented at the Special Meeting on February 12, 2021 at 8:00am. To ensure that your vote is received in
time to be counted at the upcoming Special Meeting, please vote
TODAY by internet or phone following the instructions on your proxy
card or voting instruction form.
If you have any questions or need assistance in voting your
shares, please call our proxy solicitor, Okapi Partners at (844)
343-2623 (Toll Free) or email at info@okapipartners.com
About Longview Acquisition Corp.
Longview was formed to partner with high-quality, growing
companies to facilitate their successful entry to the public
markets. Longview is sponsored by an affiliate of Glenview Capital
Management, a registered investment adviser with a track record of
creating value through constructive partnerships with companies
operating in the public markets.
About Butterfly Network
Founded by Dr. Jonathan Rothberg
in 2011, Butterfly has created the world's first handheld,
single-probe whole-body ultrasound system, Butterfly iQ. Butterfly
Network's mission is to enable universal access to superior medical
imaging, making high-quality ultrasound affordable, easy-to-use,
globally accessible, and intelligently connected, including for the
4.7 billion people around the world lacking access to ultrasound.
Through its proprietary Ultrasound-On-Chip™ technology, Butterfly
Network is paving the way for earlier detection and remote
management of health conditions around the world. The Butterfly iQ
can be purchased online today by healthcare practitioners in
the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the
Netherlands, New Zealand,
Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
Important Information about the Business Combination and
Where to Find It
In connection with the proposed business combination between
Longview Acquisition Corp. ("Longview") and Butterfly Network, Inc.
("Butterfly") (the "Business Combination"), Longview has filed with
the Securities and Exchange Commission (the "SEC") a registration
statement on Form S-4 (the "Registration Statement"), which
includes the definitive proxy statement/prospectus (the "Proxy
Statement") and certain other related documents and is both the
proxy statement distributed to holders of shares of Longview's
common stock in connection with Longview's solicitation of proxies
for the vote by Longview's stockholders with respect to the
Business Combination and other matters as may be described in the
Registration Statement, as well as the prospectus relating to the
offer and sale of the securities of Longview to be issued in the
Business Combination. The Registration Statement was declared
effective by the SEC on January 26,
2021, and Longview commenced mailing the Proxy Statement to
its stockholders on or about January 28,
2021. Longview's stockholders and other interested persons
are advised to read the Proxy Statement included in the
Registration Statement and the amendments thereto, as well as other
documents filed with the SEC in connection with the proposed
Business Combination, as these materials contain important
information about the parties to the Business Combination
Agreement, Longview and the proposed Business Combination.
Stockholders may also obtain copies of the Proxy Statement and
other documents filed with the SEC, without charge, at the SEC's
web site at www.sec.gov, or by directing a request to: Longview
Acquisition Corp., 767 Fifth Avenue, 44th Floor, New York, NY 10153, Attention: Mark Horowitz, Chief Financial Officer or to
info@longviewacquisition.com.
Participants in the Solicitation
Longview and its directors and executive officers may be deemed
participants in the solicitation of proxies from Longview's
stockholders with respect to the Business Combination. A list of
the names of those directors and executive officers and a
description of their interests in Longview is contained in the
Registration Statement for the Business Combination, and is
available free of charge at the SEC's web site at www.sec.gov, or
by directing a request to Longview Acquisition Corp., 767 Fifth
Avenue, 44th Floor, New York, NY
10153, Attention: Mark Horowitz,
Chief Financial Officer or to info@longviewacquisition.com.
Additional information regarding the interests of such participants
is contained in the Registration Statement.
Butterfly and its directors and executive officers may also be
deemed to be participants in the solicitation of proxies from the
stockholders of Longview in connection with the Business
Combination. A list of the names of such directors and executive
officers and information regarding their interests in the Business
Combination is contained in the Registration Statement.
Forward-Looking Statements
This press release includes "forward-looking statements" within
the meaning of the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. Longview's and
Butterfly's actual results may differ from their expectations,
estimates and projections and consequently, you should not rely on
these forward-looking statements as predictions of future events.
Words such as "expect," "estimate," "project," "budget,"
"forecast," "anticipate," "intend," "plan," "may," "will," "could,"
"should," "believes," "predicts," "potential," "continue," and
similar expressions (or the negative versions of such words or
expressions) are intended to identify such forward-looking
statements. These forward-looking statements include, without
limitation, Longview's and Butterfly's expectations with respect to
future performance and anticipated financial impacts of the
Business Combination, the satisfaction of the closing conditions to
the Business Combination and the timing of the completion of the
Special Meeting of Stockholders and the Business Combination. These
forward-looking statements involve significant risks and
uncertainties that could cause the actual results to differ
materially from the expected results. Most of these factors are
outside Longview's and Butterfly's control and are difficult to
predict. Factors that may cause such differences include, but are
not limited to: (1) the ability of Longview and Butterfly prior to
the Business Combination, and New Butterfly following the Business
Combination, to meet the closing conditions in the Business
Combination Agreement, including due to failure to obtain approval
of the stockholders of Longview and Butterfly or certain regulatory
approvals, or failure to satisfy other conditions to closing in the
Business Combination Agreement; (2) the occurrence of any event,
change or other circumstances, including the outcome of any legal
proceedings that may be instituted against Longview and Butterfly
following the announcement of the Business Combination Agreement
and the transactions contemplated therein, that could give rise to
the termination of the Business Combination Agreement or could
otherwise cause the transactions contemplated therein to fail to
close; (3) the inability to obtain or maintain the listing of the
combined company's Class A common stock on the New York Stock
Exchange, as applicable, following the Business Combination; (4)
the risk that the Business Combination disrupts current plans and
operations as a result of the announcement and consummation of the
Business Combination; (5) the inability to recognize the
anticipated benefits of the Business Combination, which may be
affected by, among other things, competition and the ability of the
combined company to grow and manage growth profitably and retain
its key employees; (6) costs related to the Business Combination;
(7) changes in applicable laws or regulations; (8) the inability of
the combined company to raise financing in the future; (9) the
success, cost and timing of Butterfly's and the combined company's
product development activities; (10) the inability of Butterfly or
the combined company to obtain and maintain regulatory approval for
their products, and any related restrictions and limitations of any
approved product; (11) the inability of Butterfly or the combined
company to identify, in-license or acquire additional technology;
(12) the inability of Butterfly or the combined company to maintain
Butterfly's existing license, manufacturing, supply and
distribution agreements; (13) the inability of Butterfly or the
combined company to compete with other companies currently
marketing or engaged in the development of products and services
that Butterfly is currently marketing or developing; (14) the size
and growth potential of the markets for Butterfly's and the
combined company's products and services, and each of their ability
to serve those markets, either alone or in partnership with others;
(15) the pricing of Butterfly's and the combined company's products
and services and reimbursement for medical procedures conducted
using Butterfly's and the combined company's products and services;
(16) Butterfly's and the combined company's estimates regarding
expenses, future revenue, capital requirements and needs for
additional financing; (17) Butterfly's and the combined company's
financial performance; (18) the impact of COVID-19 on Butterfly's
business and/or the ability of the parties to complete the Business
Combination; and (19) other risks and uncertainties indicated from
time to time in the proxy statement/prospectus relating to the
Business Combination, including those under "Risk Factors" in the
Registration Statement, and in Longview's other filings with the
SEC.
Longview and Butterfly caution that the foregoing list of
factors is not exclusive. Longview and Butterfly caution readers
not to place undue reliance upon any forward-looking statements,
which speak only as of the date made. Longview and Butterfly do not
undertake or accept any obligation or undertaking to release
publicly any updates or revisions to any forward-looking statements
to reflect any change in its expectations or any change in events,
conditions or circumstances on which any such statement is
based.
No Offer or Solicitation
This press release shall not constitute a solicitation of a
proxy, consent or authorization with respect to any securities or
in respect of the Business Combination. This press release shall
also not constitute an offer to sell or the solicitation of an
offer to buy any securities, nor shall there be any sale of
securities in any states or jurisdictions in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such jurisdiction.
No offering of securities shall be made except by means of a
prospectus meeting the requirements of Section 10 of the Securities
Act of 1933, as amended.
Media Contact:
Longview Acquisition Corp.
John Rodin
info@longviewacquisition.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/longview-acquisition-corp-reminds-shareholders-to-vote-in-favor-of-the-business-combination-with-butterfly-network-inc-301224923.html
SOURCE Longview Acquisition Corp.